Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)
PHASE3CompletedINTERVENTIONAL
Enrollment
449
Participants
Timeline
Start Date
January 9, 2015
Primary Completion Date
April 27, 2015
Study Completion Date
April 27, 2015
Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG
Desloratadine 5 mg
Desloratadine 5 mg tablets
DRUG
Placebo
Placebo tablets
All Listed Sponsors
lead
Organon and Co
INDUSTRY
NCT02320396 - Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204) | Biotech Hunter | Biotech Hunter